Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients

Bisphosphonates are well known inhibitors of osteoclast activity and thus may be employed to influence osteoblast activity. The present study was designed to evaluate the in vivo effects of zoledronic acid (ZA) on the proliferation and osteoblastic commitment of mesenchymal stem cells (MSC) in osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalle Carbonare, Luca, Mottes, Monica, Malerba, Giovanni, Mori, Antonio, Zaninotto, Martina, Plebani, Mario, Dellantonio, Alessandra, Valenti, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486083/
https://www.ncbi.nlm.nih.gov/pubmed/28608802
http://dx.doi.org/10.3390/ijms18061261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486083/
https://www.ncbi.nlm.nih.gov/pubmed/28608802
http://dx.doi.org/10.3390/ijms18061261

Ejemplares similares